(%)
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
- Ownership
-
X4 Pharmaceuticals, Inc. Insider Trading
* In original currency USD
Loading Data
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price | Total Amount |
|---|---|---|---|---|---|---|---|---|
| Tuesday, May 20th, 2025 | Thoren Natasha Fay | officer: Chief Legal Officer | 9,462 | A-Award | A | 3,333 | 0.00 USD | 0 USD |
| Monday, June 9th, 2025 | Stewart Murray | director | 7,883 | A-Award | A | 1,500 | 0.00 USD | 0 USD |
| Monday, June 9th, 2025 | de Craecker Francoise | director | 4,722 | A-Award | A | 1,500 | 0.00 USD | 0 USD |
| Monday, June 9th, 2025 | Bridger Gary | director | 4,722 | A-Award | A | 1,500 | 0.00 USD | 0 USD |
| Monday, June 9th, 2025 | Woods Keith | director | 6,000 | A-Award | A | 1,500 | 0.00 USD | 0 USD |
| Monday, June 9th, 2025 | MCGIRR DAVID W J | director | 4,722 | A-Award | A | 1,500 | 0.00 USD | 0 USD |
| Monday, June 9th, 2025 | WYZGA MICHAEL S | director | 5,555 | A-Award | A | 1,500 | 0.00 USD | 0 USD |
| Tuesday, May 20th, 2025 | Thoren Natasha Fay | officer: Chief Legal Officer | 6,984 | 0 | 0.00 USD | 0 USD | ||
| Tuesday, May 20th, 2025 | Thoren Natasha Fay | officer: Chief Legal Officer | 0 | 8,166 | 32.70 USD | 267,028 USD | ||
| Friday, May 16th, 2025 | Baldry Mark | officer: Chief Commercial Officer | 25,337 | A-Award | A | 1,032 | 2.48 USD | 2,561 USD |
| Friday, May 16th, 2025 | Baldry Mark | officer: Chief Commercial Officer | 25,337 | P-Purchase | A | 1,032 | 2.48 USD | 2,561 USD |
| Wednesday, February 12th, 2025 | Arbet-Engels Christophe | officer: Chief Medical Officer | 864,207 | A-Award | A | 850,000 | 0.00 USD | 0 USD |
| Wednesday, February 12th, 2025 | Mostafa Adam S. | officer: Chief Financial Officer | 850,000 | A-Award | A | 850,000 | 0.00 USD | 0 USD |
| Wednesday, February 12th, 2025 | Ragan Paula | director, officer: President and CEO | 3,337,386 | A-Award | A | 2,250,000 | 0.00 USD | 0 USD |
| Wednesday, February 12th, 2025 | Baldry Mark | officer: Chief Commercial Officer | 729,173 | A-Award | A | 600,000 | 0.00 USD | 0 USD |
| Friday, November 15th, 2024 | Baldry Mark | officer: Chief Commercial Officer | 129,173 | P-Purchase | A | 13,404 | 0.34 USD | 4,598 USD |
| Friday, May 17th, 2024 | Baldry Mark | officer: Chief Commercial Officer | 115,769 | P-Purchase | A | 21,646 | 0.68 USD | 14,654 USD |
| Wednesday, February 12th, 2025 | DiBiase Mary | officer: Chief Operating Officer | 1,140,980 | A-Award | A | 650,000 | 0.00 USD | 0 USD |
| Thursday, January 23rd, 2025 | Ragan Paula | director, officer: President and CEO | 1,163,859 | A-Award | A | 169,940 | 0.00 USD | 0 USD |
| Friday, January 24th, 2025 | Ragan Paula | director, officer: President and CEO | 1,087,386 | S-Sale | D | 76,473 | 0.45 USD | 34,719 USD |
| Thursday, January 23rd, 2025 | Mostafa Adam S. | officer: Chief Financial Officer | 74,773 | A-Award | A | 74,773 | 0.00 USD | 0 USD |
| Friday, January 24th, 2025 | Mostafa Adam S. | officer: Chief Financial Officer | 0 | S-Sale | D | 74,773 | 0.45 USD | 33,947 USD |
| Thursday, January 23rd, 2025 | Baldry Mark | officer: Chief Commercial Officer | 123,282 | A-Award | A | 74,773 | 0.00 USD | 0 USD |
| Friday, January 24th, 2025 | Baldry Mark | officer: Chief Commercial Officer | 94,123 | S-Sale | D | 29,159 | 0.45 USD | 13,241 USD |
| Thursday, January 23rd, 2025 | DiBiase Mary | officer: Chief Operating Officer | 513,238 | A-Award | A | 61,178 | 0.00 USD | 0 USD |
| Friday, January 24th, 2025 | DiBiase Mary | officer: Chief Operating Officer | 490,980 | S-Sale | D | 22,258 | 0.45 USD | 10,094 USD |
| Thursday, January 23rd, 2025 | Arbet-Engels Christophe | officer: Chief Medical Officer | 25,831 | A-Award | A | 25,831 | 0.00 USD | 0 USD |
| Friday, January 24th, 2025 | Arbet-Engels Christophe | officer: Chief Medical Officer | 14,207 | S-Sale | D | 11,624 | 0.45 USD | 5,284 USD |
| Friday, November 15th, 2024 | Ragan Paula | director, officer: President and CEO | 993,919 | S-Sale | D | 31,897 | 0.39 USD | 12,583 USD |
| Tuesday, October 15th, 2024 | Ragan Paula | director, officer: President and CEO | 1,025,816 | S-Sale | D | 31,897 | 0.56 USD | 17,926 USD |
| Friday, October 4th, 2024 | Mostafa Adam S. | officer: Chief Financial Officer | 230,645 | A-Award | A | 230,645 | 0.00 USD | 0 USD |
| Monday, October 7th, 2024 | Mostafa Adam S. | officer: Chief Financial Officer | 0 | S-Sale | D | 230,645 | 0.55 USD | 126,901 USD |
| Friday, October 4th, 2024 | Baldry Mark | officer: Chief Commercial Officer | 59,636 | A-Award | A | 34,946 | 0.00 USD | 0 USD |
| Monday, October 7th, 2024 | Baldry Mark | officer: Chief Commercial Officer | 48,509 | S-Sale | D | 11,127 | 0.58 USD | 6,506 USD |
| Friday, October 4th, 2024 | Ragan Paula | director, officer: President and CEO | 1,297,149 | A-Award | A | 532,081 | 0.00 USD | 0 USD |
| Monday, October 7th, 2024 | Ragan Paula | director, officer: President and CEO | 1,057,713 | S-Sale | D | 239,436 | 0.55 USD | 131,522 USD |
| Friday, October 4th, 2024 | DiBiase Mary | officer: Chief Operating Officer | 519,755 | A-Award | A | 230,645 | 0.00 USD | 0 USD |
| Monday, October 7th, 2024 | DiBiase Mary | officer: Chief Operating Officer | 452,060 | S-Sale | D | 67,695 | 0.57 USD | 38,329 USD |
| Friday, October 4th, 2024 | Taveras Arthur | officer: Chief Scientific Officer | 464,946 | A-Award | A | 230,645 | 0.00 USD | 0 USD |
| Monday, October 7th, 2024 | Taveras Arthur | officer: Chief Scientific Officer | 388,026 | S-Sale | D | 76,920 | 0.56 USD | 43,306 USD |
| Monday, September 9th, 2024 | DiBiase Mary | officer: Chief Operating Officer | 289,110 | S-Sale | D | 2,642 | 0.66 USD | 1,738 USD |
| Monday, June 10th, 2024 | de Craecker Francoise | director | 96,667 | A-Award | A | 45,000 | 0.00 USD | 0 USD |
| Monday, June 10th, 2024 | Aliski William | director | 96,667 | A-Award | A | 45,000 | 0.00 USD | 0 USD |
| Monday, June 10th, 2024 | MCGIRR DAVID W J | director | 96,667 | A-Award | A | 45,000 | 0.00 USD | 0 USD |
| Monday, June 10th, 2024 | Stewart Murray | director | 191,504 | A-Award | A | 45,000 | 0.00 USD | 0 USD |
| Monday, June 10th, 2024 | Bridger Gary | director | 96,667 | A-Award | A | 45,000 | 0.00 USD | 0 USD |
| Monday, June 10th, 2024 | Woods Keith | director | 135,000 | A-Award | A | 45,000 | 0.00 USD | 0 USD |
| Monday, June 10th, 2024 | Lawton Alison Frances | director | 96,667 | A-Award | A | 45,000 | 0.00 USD | 0 USD |
| Monday, June 10th, 2024 | WYZGA MICHAEL S | director | 121,667 | A-Award | A | 45,000 | 0.00 USD | 0 USD |
| Monday, March 11th, 2024 | Taveras Arthur | officer: Chief Scientific Officer | 234,301 | S-Sale | D | 14,235 | 0.88 USD | 12,552 USD |
| Monday, March 11th, 2024 | Ragan Paula | director, officer: President and CEO | 765,068 | S-Sale | D | 49,678 | 0.88 USD | 43,856 USD |
| Monday, March 11th, 2024 | Mostafa Adam S. | officer: Chief Financial Officer | 0 | S-Sale | D | 52,500 | 0.88 USD | 46,347 USD |
| Monday, March 11th, 2024 | DiBiase Mary | officer: Chief Operating Officer | 291,752 | S-Sale | D | 15,409 | 0.88 USD | 13,591 USD |
| Tuesday, February 13th, 2024 | Arbet-Engels Christophe | officer: Chief Medical Officer | 180,816 | A-Award | A | 180,816 | 0.92 USD | 166,532 USD |
| Tuesday, February 13th, 2024 | Arbet-Engels Christophe | officer: Chief Medical Officer | 475,831 | A-Award | A | 475,831 | 0.92 USD | 438,240 USD |
| Tuesday, February 13th, 2024 | Mostafa Adam S. | officer: Chief Financial Officer | 523,414 | A-Award | A | 523,414 | 0.92 USD | 482,064 USD |
| Tuesday, February 13th, 2024 | DiBiase Mary | officer: Chief Operating Officer | 428,248 | A-Award | A | 428,248 | 0.92 USD | 394,416 USD |
| Tuesday, February 13th, 2024 | Ragan Paula | director, officer: President and CEO | 1,189,578 | A-Award | A | 1,189,578 | 0.92 USD | 1,095,601 USD |
| Tuesday, February 13th, 2024 | Baldry Mark | officer: Chief Commercial Officer | 523,414 | A-Award | A | 523,414 | 0.92 USD | 482,064 USD |
| Tuesday, February 13th, 2024 | Taveras Arthur | officer: Chief Scientific Officer | 428,248 | A-Award | A | 428,248 | 0.92 USD | 394,416 USD |
| Monday, February 12th, 2024 | DiBiase Mary | officer: Chief Operating Officer | 307,161 | S-Sale | D | 3,683 | 1.01 USD | 3,709 USD |
| Monday, February 12th, 2024 | Taveras Arthur | officer: Chief Scientific Officer | 248,536 | S-Sale | D | 787 | 1.01 USD | 793 USD |
| Monday, February 12th, 2024 | Ragan Paula | director, officer: President and CEO | 814,746 | S-Sale | D | 21,695 | 1.01 USD | 21,892 USD |
| Monday, February 12th, 2024 | Mostafa Adam S. | officer: Chief Financial Officer | 52,500 | S-Sale | D | 27,721 | 1.01 USD | 27,973 USD |
| Wednesday, November 1st, 2023 | Ragan Paula | director, officer: President and CEO | 876,347 | S-Sale | D | 199,531 | 0.73 USD | 145,658 USD |
| Friday, November 3rd, 2023 | Ragan Paula | director, officer: President and CEO | 836,441 | S-Sale | D | 39,906 | 0.90 USD | 35,915 USD |
| Wednesday, November 1st, 2023 | Mostafa Adam S. | officer: Chief Financial Officer | 80,221 | S-Sale | D | 230,645 | 0.73 USD | 168,371 USD |
| Wednesday, November 1st, 2023 | DiBiase Mary | officer: Chief Operating Officer | 310,844 | S-Sale | D | 67,695 | 0.73 USD | 49,417 USD |
| Wednesday, November 1st, 2023 | Baldry Mark | officer: Chief Commercial Officer | 24,690 | S-Sale | D | 10,257 | 0.73 USD | 7,488 USD |
| Wednesday, November 1st, 2023 | Taveras Arthur | officer: Chief Scientific Officer | 249,323 | S-Sale | D | 67,695 | 0.73 USD | 49,417 USD |
| Tuesday, October 31st, 2023 | Mostafa Adam S. | officer: Chief Financial Officer | 310,866 | A-Award | A | 230,645 | 0.00 USD | 0 USD |
| Tuesday, October 31st, 2023 | Baldry Mark | officer: Chief Commercial Officer | 34,947 | A-Award | A | 34,947 | 0.00 USD | 0 USD |
| Tuesday, October 31st, 2023 | Taveras Arthur | officer: Chief Scientific Officer | 317,018 | A-Award | A | 230,645 | 0.00 USD | 0 USD |
| Tuesday, October 31st, 2023 | Ragan Paula | director, officer: President and CEO | 1,075,878 | A-Award | A | 532,081 | 0.00 USD | 0 USD |
| Tuesday, October 31st, 2023 | DiBiase Mary | officer: Chief Operating Officer | 378,539 | A-Award | A | 230,645 | 0.00 USD | 0 USD |
| Monday, October 16th, 2023 | Woods Keith | director | 90,000 | A-Award | A | 90,000 | 0.00 USD | 0 USD |
| Monday, October 16th, 2023 | Woods Keith | director: | 0 | 0 | 0.00 USD | 0 USD | ||
| Friday, September 8th, 2023 | DiBiase Mary | officer: Chief Operating Officer | 147,894 | S-Sale | D | 2,642 | 1.25 USD | 3,300 USD |
| Thursday, August 31st, 2023 | Arbet-Engels Christophe | officer: Chief Medical Officer | 1,250,000 | A-Award | A | 1,250,000 | 1.28 USD | 1,600,000 USD |
| Friday, August 18th, 2023 | WYZGA MICHAEL S | director | 76,667 | P-Purchase | A | 25,000 | 1.20 USD | 29,875 USD |
| Wednesday, August 16th, 2023 | Arbet-Engels Christophe | officer | 0 | 0 | 0.00 USD | 0 USD | ||
| Wednesday, August 9th, 2023 | Stewart Murray | director, officer: Interim Chief Medical Officer | 276,560 | A-Award | A | 269,893 | 0.00 USD | 0 USD |
| Thursday, August 10th, 2023 | Stewart Murray | director, officer: Interim Chief Medical Officer | 146,504 | S-Sale | D | 130,056 | 1.06 USD | 137,859 USD |
| Friday, June 30th, 2023 | DiBiase Mary | officer: Chief Operating Officer | 150,536 | S-Sale | D | 464 | 1.89 USD | 877 USD |
| Friday, June 30th, 2023 | Mostafa Adam S. | officer: Chief Financial Officer | 80,221 | S-Sale | D | 2,641 | 1.89 USD | 4,992 USD |
| Friday, June 23rd, 2023 | DiBiase Mary | officer: Chief Operating Officer | 151,000 | S-Sale | D | 857 | 1.93 USD | 1,654 USD |
| Friday, June 23rd, 2023 | Mostafa Adam S. | officer: Chief Financial Officer | 82,862 | S-Sale | D | 5,417 | 1.93 USD | 10,455 USD |
| Friday, June 23rd, 2023 | Ragan Paula | director, officer: President and CEO | 543,797 | S-Sale | D | 6,724 | 1.92 USD | 12,910 USD |
| Thursday, June 15th, 2023 | DiBiase Mary | officer: Chief Operating Officer | 151,857 | S-Sale | D | 857 | 2.23 USD | 1,911 USD |
| Thursday, June 15th, 2023 | Mostafa Adam S. | officer: Chief Financial Officer | 88,279 | S-Sale | D | 5,417 | 2.22 USD | 12,026 USD |
| Thursday, June 15th, 2023 | Ragan Paula | director, officer: President and CEO | 550,521 | S-Sale | D | 6,724 | 2.23 USD | 14,995 USD |
| Tuesday, June 13th, 2023 | Aliski William | director | 51,667 | A-Award | A | 45,000 | 0.00 USD | 0 USD |
| Tuesday, June 13th, 2023 | Bridger Gary | director | 51,667 | A-Award | A | 45,000 | 0.00 USD | 0 USD |
| Tuesday, June 13th, 2023 | MCGIRR DAVID W J | director | 51,667 | A-Award | A | 45,000 | 0.00 USD | 0 USD |
| Tuesday, June 13th, 2023 | WYZGA MICHAEL S | director | 51,667 | A-Award | A | 45,000 | 0.00 USD | 0 USD |
| Tuesday, June 13th, 2023 | de Craecker Francoise | director | 51,667 | A-Award | A | 45,000 | 0.00 USD | 0 USD |
| Tuesday, June 13th, 2023 | Lawton Alison Frances | director | 51,667 | A-Award | A | 45,000 | 0.00 USD | 0 USD |
| Wednesday, May 31st, 2023 | Ragan Paula | director, officer: President and CEO | 557,245 | S-Sale | D | 6,292 | 1.95 USD | 12,269 USD |
| Friday, March 10th, 2023 | DiBiase Mary | officer: Chief Operating Officer | 152,714 | S-Sale | D | 18,192 | 0.84 USD | 15,281 USD |
| Friday, March 10th, 2023 | Mostafa Adam S. | officer: Chief Financial Officer | 93,696 | S-Sale | D | 52,500 | 0.84 USD | 44,100 USD |
